Nutex Health Inc(NUTX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:35 PM ET (Korea 10/31 08:35)
Full metrics table
| Index | RUT | P/E | 7.92 | EPS (ttm) | 25.28 | Insider Own | 32.87% | Shs Outstand | 6.8M | Perf Week | -4.5% |
| Market Cap | 1.37B | Forward P/E | 7.33 | EPS next Y | -0.18% | Insider Trans | -0.01% | Shs Float | 4.6M | Perf Month | -5.73% |
| Enterprise Value | 1.62B | PEG | 0.2 | EPS next Q | 5.54 | Inst Own | 43.64% | Short Float | 26.89% | Perf Quarter | 30.88% |
| Income | 0.18B | P/S | 1.62 | EPS this Y | 161.13% | Inst Trans | 1.28% | Short Ratio | 7.96 | Perf Half Y | 43.4% |
| Sales | 0.85B | P/B | 3.47 | EPS next 5Y | 36.68% | ROA | 19.93% | Short Interest | 1.24M | Perf YTD | 21.58% |
| Book/sh | 57.62 | P/C | 6.62 | EPS past 3/5Y | - | ROE | 57.16% | 52W High | -11.5% ($226.16) | Perf Year | 60.76% |
| Cash/sh | 30.24 | P/FCF | 5 | Sales past 3/5Y | 58.62% 253.48% | ROIC | 24.87% | 52W Low | 138.3% ($83.99) | Perf 3Y | 589.22% |
| Dividend Est. | - | EV/EBITDA | 4.21 | EPS Y/Y TTM | 155.98% | Gross Margin | 51.26% | Volatility(W/M) | 5.4% 5.39% | Perf 5Y | -66.64% |
| Dividend TTM | - | EV/Sales | 1.92 | Sales Y/Y TTM | 6.88% | Oper. Margin | 43.02% | ATR (14) | 10.83 | Perf 10Y | -98.14% |
| Dividend Ex-Date | - | Quick Ratio | 4.96 | EPS Q/Q | 417.67% | Profit Margin | 21.25% | RSI (14) | 46.68 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5 | Sales Q/Q | -13.62% | SMA20 | -2.5% ($205.28) | Beta | 0.65 | Target Price | $296.17 |
| Payout | - | Debt/Eq | 0.88 | Earnings | 2026/11/5 | SMA50 | -1.52% ($203.24) | Rel Volume | 0.77 | Prev Close | $210.1 |
| Employees | 944 | LT Debt/Eq | 0.83 | EPS/Sales Surpr. | 89.34% -1.99% | SMA200 | 33.04% ($150.44) | Avg Volume(3M) | 0.16M | Price | $200.15 |
| IPO | 2014/4/24 | Option/Short | No/Yes | Trades | 3855 | Volume | 120,065 | Change | -4.74% |
🏥 Nutex Health (NUTX) is a U.S. healthcare company operating a physician-led, integrated healthcare delivery system. Its model combines micro-hospitals and hospital outpatient departments across multiple states with a risk-bearing network of primary care physicians, and is characterized by rapid revenue growth centered on emergency and high-acuity care.
Over the past 1 year, on the higher side
12% below its 1-year high.
Traded less than usual. That is 77% of its average volume.
Next earnings report: November 5
5 days to go.
NUTX makes money exceptionally well
Of every $100 in sales, $43.02 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +161.1% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $733. Peers typically go for $1,787. Compared with its own 2-year average, it is 18% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -66.6%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Short interest is a burden
26.9% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
XHS State Street SPDR S&P Health Care Services ETF 0.02% 
RNIN Bushido Capital US SMID Cap Equity ETF 0.01% 
FDM First Trust Dow Jones Select Microcap Index Fund 0.01% 
ABLS Abacus FCF Small Cap Leaders ETF <0.01% 
VAMO Cambria ETF Trust Cambria Value and Momentum ETF <0.01% It ranks #29 of 48 in the industry
Based on market cap of $1B.
PNTG#27 Pennant Group Inc $1B PER 45.9 
AGL#28 Agilon Health Inc $1B PER - NUTX#29 Nutex Health Inc $1B PER 7.9 
USPH#30 U.S. Physical Therapy Inc $1B PER 507.0 
INNV#31 InnovAge Holding Corp $1B PER - 
FAQ
What kind of company is NUTX?
NUTX belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of NUTX?
The market cap of NUTX is approximately $1.4B, ranking 2,344 within its sector.
What is the P/E ratio of NUTX?
NUTX has a P/E ratio of approximately 7.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NUTX?
NUTX has recorded a 52-week high of $226.16 and a low of $83.99.
